SHR9549 in ER Positive HER2 Negative Advanced Breast Cancer
Clinical trial NCT03596658 · TERMINATED
Trial details
- NCT number
- NCT03596658
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-25
- Primary completion
- 2019-10-14
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.